Cambridge Healthtech Institute’s 19th Annual

Fragment-Based Drug Discovery

Fragment-Based Lead Design (FBLD) for New Small Molecule Therapeutic Candidates

APRIL 2 - 3, 2024

Fragment-based drug discovery (FBDD) approaches have proven fruitful for finding new drug candidates, especially against non-enzymatic intracellular targets such as protein-protein interactions (PPIs), including molecular glues, that lack a typical pocket for an inhibitor to bind within. Cambridge Healthtech Institute's Fragment-Based Drug Discovery conference covers the latest refinements to fragment libraries, innovations in biophysical approaches for screening fragment hits, and case studies of growing a fragment hit into a drug lead and beyond. The challenges of integrating information from other lead generation approaches like DNA-encoded libraries, and other timely topics, will also be on the agenda and/or part of discussions with fellow medicinal chemists.

For more details on the conference, please contact:

Anjani Shah, PhD

Senior Conference Director and Lead Content Director for Drug Discovery Chemistry

Cambridge Healthtech Institute

Phone: (+1) 781-247-6252

Email: ashah@healthtech.com

For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431

Email: kskahan@healthtech.com